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ABSTRACT
Background: Tissue engineering based approaches have received 
much attention. Incorporation of chitosan and carbonate apatite (CA) 
improve its capability. Human mesenchymal stem cells (hMSCs) is 
viable for xenogenic transplantation. The purpose of this study was 
to fabricate and evaluate the osteogenic potential differentiation 
of human amnion mesenchymal stem cell with carbonate apatite–
chitosan scaffolds (CA-ChSs) for tissue engineering. 
Method: Human amniotic membrane was procured from 
using cesarean section. Soncini’s protocol was employed for the 
isolation procedure. The cells cultured on collagen-coated dishes 
using Dulbecco’s minimal essential medium (DMEM)/F12 (1:1). 
A chitosan powder of medium molecular weight deacetylated 
chitin, poly(D(glucosamine) was used and mixed with CA. 
Immunocytochemistry and flowcytometry used for phenotypic 
characterization of hAMSC. 
Result: Amniotic membrane obtained using cesarean section under 
aseptic condition did not exhibit any growth of cell cultures which 
were not contaminated. Immunocytochemistry testing revealed that 
the target cells expressed strong mesenchymal stem cell marker CD 
105. Characterization at passage 10 showed that CD44 was the most 
significant and abundant surface receptors. The number of viable 
cells in chitosan-carbonate apatite was 66.59%. Scanning electron 
microscope (SEM) observation revealed that CA-ChSs had three-
dimensional structure with many pores and hAMSc could attached 
and proliferation among the porosity of the scaffold. The formation of 
calcium in the cell as an indicator of osteoblast cells was detected using 
Alizarin Red solution. 
Conclusion: hAMSc harvested from human amniotic membrane 
seeding in CA-ChSs had the capability for in vitro osteogenesis makes 
them be the one of the potential options for bone tissue engineering.
Keywords: human amniotic membrane mesenchymal stem cells, chitosan-carbonate apatite, scaffold, MSC phenotypic characterization, MTT 
assay.
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Osteogenic potential differentiation of human 
amnion mesenchymal stem cell with chitosan-
carbonate apatite scaffold (in vitro study)
Michael J.K. Kamadjaja,1* Sherman Salim,1 Fedik A. Rantam2,3,4
INTRODUCTION
Bone tissue regeneration using the tissue engi-
neering technique has been attempted in order to 
solve problems, such as complications in wound 
healing, donor pain, insufficient supply of bone, 
immunogenic reaction and disease transmission 
from donor tissues and fluids. Many efforts have 
been conducted to create three dimentional scaf-
folds that provide adequate support as extracellular 
matrix that allows the cells to proliferate, dfiferen-
tiate, and maintain bodily functions. The property 
for an ideal scaffolds are non-toxic, suitable micro-
structure, controllable biodegrability and, as well 
as suitable mechanical properties. Scaffolds are 
expected to be capable of cell adhesion promotion 
and retaining their functions.1,2,3,4
Chitosan can be generated by the deacetylation of 
chitin and is composed of glucosamine with a vari-
able frequency of N-acetyl-D-glucosamine units.4,5 
The mechanical strength of chitosan can be varied 
by altering its microstructure, molecular weight, 
degree of deacetylation, and crystallinity. Recent 
studies have shown chitosan promotes osteoblast 
growth and differentiation in cell culture and 
shown favorable properties such as bacteriostatic, 
hemostatic, and cholesterol lowering properties.6,7 
However, there still exist some problems, such as 
allergic reactions and low solubility, because of the 
low degree of deacetylation of chitosan. Recently, 
highly deacetylated chitosan has been developed 
and is expected to solve these inherent problems of 
presently available chitosan.8 
It is difficult to conclude that a single scaffold 
using an organic material possesses all the criteria 
required for successful bone tissue engineering. 
Chitosan itself has numerous advantages in biomed-
ical applications, but is not osteoconductive and has 
not enough bone formation ability. One approach 
to overcome these disadvantages is to design 
composite substances that combine the strengths of 
different materials and minimize their drawbacks. 
Incorporation of chitosan and calcium phospate 
substances for example hydroxyapatite (HA), β-tri-
calcium phosphate (β-TCP), and carbonate apatite 
(CA) could improve mechanical properties and 
1Department of Prosthodontic, 
Faculty of Dental Medicine, 
Airlangga University, Surabaya-
Indonesia
2Stem cell Research and 
Development Center, Airlangga 
University, Surabaya-Indonesia
3Regenerative Medicine & Stem 
Cell Center, RSUD Dr. Soetomo 
Teaching Hospital / School of 
Medicine Airlangga University, 
Surabaya-Indonesia
4Virology and Immunology, 
Microbiology Department, Faculty 
of Veterinarian Medicine, Airlangga 
University, Surabaya-Indonesia
*Correspondence to: Michael 
J.K. Kamadjaja, Department of 
Prosthodontic, Faculty of Dental 
Medicine, Airlangga University, 
Surabaya, Indonesia 
josef_310563@yahoo.com
Volume No.: 5
Issue: 3
First page No.: 71
P-ISSN.2089-1180
E-ISSN.2302-2914
Doi: http://dx.doi.org/10.15562/bmj.v5i3.296
ORIGINAL ARTICLE
72 Published by DiscoverSys | Bali Med J 2016; 5 (3): 71-77 | doi: 10.15562/bmj.v5i3.296
ORIGINAL ARTICLE
enhance biological properties as well.9,10 Carbonate 
apatite–chitosan scaffolds (CA-ChSs) had a 
three-dimensional interconnected porous struc-
ture, good retentive form, and the ability to support 
the proliferation and differentiation of osteoblasts.11 
Human mesenchymal stem cells (hMSCs) is 
viable for xenogenic transplantation because of it’s 
favorable properties such as low immunogenic-
ity, immense proliferation rate, and the potential 
to multi-differentiate. hMSCs serves as the best 
option for seeding source for tissue engineering. 
Mesenchymal stem cells (MSCs) derived from 
bone marrow is currently the best source of autol-
ogous stem cells, and often used as seeding cells 
for cell therapy and tissue engineering.12,13 MSCs 
best properties are its potent regeneration potential 
and immunosuppressive properties which proves 
important for the use of allografts. The use of MSCs 
have already been applied for clinical trials in vari-
ous studies, such as hematopoietic facilitation and 
immune reconstitution after hematopoietic stem 
cells transplantation.14,15
The human placenta especially the amniotic 
membrane is source of vast amounts of stem cells 
which is comprised of epithelial and stromal cell. 
There are recent reports that have shown stro-
mal cells of the human amniotic membrane, also 
known as human amniotic mesenchymal stem 
cells (hAMSC), has similar characteristics to 
bone marrow mesenchymal stem cell. hAMSC 
was proven to be have the ability to differentiate 
itself into three forms of germ layer whilst having 
anti-inflammatory and low immunogenicity prop-
erties.14,16 Clinical Application of human amniotic 
membrane-derived stem cell has advantages over 
autogenous bone marrow-derived stem cell, this 
is due to lack of morbidty during procurement 
procedures and the number of stem cells unlimited 
available. Moreover, patient’s age and health condi-
tion highly influence the quality of autogenous 
BM-MSC. In the case of embryonic stem cells the 
isolation of hAMSC do not cause any harm to the 
embryo therefore leaving no any legal and ethical 
issues.17
This study is aimed to fabricate and evaluate 
the osteogenic potential diferentiation of human 
amnion mesenchymal stem cell with carbonate 
apatite-chitosan scaffolds (CA-ChSs) for tissue 
engineering.
MATERIALS AND METHODS
Human Amniotic Membrane Procurement
Human amniotic membrane was procured from 
using cesarean section which was performed at 
the Central Operating Theatre RSUD Dr. Soetomo 
Teaching Hospital Surabaya. Committee for Ethics 
on Health Researches, RSUD Dr. Soetomo legally 
and ethically approved the methods for this study. 
Fresh amnion was mechanically extracted from the 
chorion, washed three times in phosphate buffered 
saline (PBS) to remove excess blood, and soaked in 
Ringer Lactate solution containing gentamycin and 
amphotericin B based on Hendrijantini.18
Isolation and Culture of hAMSC 
Isolation and culture of hAMSC were performed 
at Stem Cell Research and Development Center, 
Airlangga University, Surabaya. Soncini’s protocol 
was employed for the isolation procedure. The 
amniotic membrane was cut into small fine pieces 
and subjected to 0.25% trypsin to remove the 
epithelial cells, and subsequently after centrifuga-
tion the supernatant was removed in which this 
protocol was done twice. Crushed tissue was then 
subjected to PBS containing 0.75 mg/ml collage-
nase IV (Sigma-Aldrich, St. Louis, MO, USA) and 
0.075 mg/mL DNase I (Takara Bio, Shiga, Japan), 
incubated at 37˚C for 60 minutes. The sample was 
then filtrated using cell strainer and pellet collec-
tion after centrifugation for 5 minutes the cells 
were finally obtained. The single cells collected 
then were cultured on collagen-coated dishes using 
Dulbecco’s minimal essential medium (DMEM)/
F12 (1:1) (Gibco BRL, Gaithersburg, MD, USA), 
added with human leukemia inhibitory factor (10 
ng/mL) and fetal bovine serum (Gibco BRL). Then 
every three days’ medium was changed and when 
confluence reached 80% cell splitting was done 
employing trypsin. Half to two thirds of the cells 
were then replated using the same medium onto 
new dish.19,20
Preparations of CA-ChSs
A chitosan powder of medium molecular weight 
deacetylated chitin, poly(D(glucosamine) from 
Sigma-Aldrich was used throughout the experi-
ments. 200 mg of chitosan powders were dissolved 
in 5 ml acetic acid in room temperature, shaken for 
15 min, neutralized using 15 ml NaOH solution in 
order to obtain chitosan gels. Then 100 mg of CA 
were homogenously mixed with the chitosan gels 
and centrifuged at 1500 rpm for 10 min to prepare 
CA-Ch gels. After the removal of excess water, 
CA-Ch gels was then transferred into cylindrical 
molds (diameter: 5 mm, height: 2 mm), frozen 
at -80°C for 2 hours and transferred into the 
freeze-drying machine.11
In order to remove alkali salts as ions, desali-
nation of CA-ChSs was conducted. One hundred 
microliters of distilled water were added to non- 
desalinated CA-ChSs and transferred into a dial-
ysis tube. The tube was then placed in tap water 
for 24  hours and frozen at -80°C for 2 hours. 
73Published by DiscoverSys | Bali Med J 2016; 5 (3): 71-77 | doi: 10.15562/bmj.v5i3.296
ORIGINAL ARTICLE
Desalinated CA-ChSs was obtained after drying 
in the freeze drying machine at -54°C for 24 hours 
(figure 1). All the materials were exposed to UV 
light for 2 hours of sterilization before using them 
in cell culture experiments.11
Phenotypic Characterization of hAMSC 
IMMUNOCYTOCHEMISTRY 
Cultured cells were then plated onto coverslips 
and after having incubated at 37˚C for 1-2 hours, 
preserved with formaldehyde 10% for 15 minutes. 
The coverslips were then rinsed four times using 
PBS and dried for few minutes. The cells were 
blocked using PBS and FBS 1% for 15-30 minutes 
and then using PBS the coverslips was washed 
four times. The cells were then applied with FITC-
labelled monoclonal antibody anti-human CD 
105 and CD 45 and incubated for 60 minutes. The 
cells were rinsed with PBS twice having done so 
the cells were ready for analysis using fluoresence 
microscope.
FLOWCYTOMETRY 
Cultured hAMSCs were then trypsinized 
and suspended in DMEM, washed with PBS, 
and preserved in formaldehyde 10% for 10 minutes 
and finally immersed in 10% BSA for one hour. The 
cells were incubated using Human MSCs Analysis 
Kit (BD StemflowTM, BD Biosciences) alongside 
primary antibodies mouse antihuman CD44, CD73, 
CD90, CD105, and negative cocktail contain-
ing CD45, CD34, CD19, CD11b, HLA-DR for 
40 minutes. Unbound antibodies were then removed 
by washing using PBS. FITC-conjugated anti-mouse 
antibody were used to label the bound primary anti-
bodies then washed with PBS. Subsequently the cells 
were analyzed using FACS Calibur flowcytometer 
(BD Biosciences, Franklin Lakes, NJ, USA).
Cell Proliferation Measurement on CA-ChSs
Human Amniotic Mesenchymal Stem Cells were 
obtained by tripsinization from a petri disc that 
contains 2 × 106 cells and resuspended in DMEM/
F12 that contains 10% FBS, 100 U penicillin, 0,1 
mg/mL streptomycin and 2 mM L-glutamine and 
centrifuged. Cells were added into culture well 96 
(M96) to a density of 5 × 104 cell/well and incu-
bated for 24 hours in 37oC and CO2 5%. After 
getting 80% of cell proliferation, CA-Ch scaffold 
was put into the well and 100 µL of medium was 
added to each well. The cells were incubated again 
for 20 hours in 37oC and CO2 5%. 5 mg/mL of 
MTT reagent (25 µL/well) was added to each well, 
incubated for 4 hours and was examined under 
inverted microscope. Scaffold and medium were 
removed and sDMSO was added to each well 
(200  µL/well). The absorbance was read by using 
Elisa reader at 595 nm and the number of living 
cells were determined utilizing MTT assay using 
Cell Counting Kit.
SEM Images of CA-ChSs
Scaffold that has been seeded with hAMSC, fixated 
with glutaraldehyde 2% for 2-3 hours at 40°C, 
washing by PBS solution 3 times for each 5 minutes. 
After that the solution was changed by osmic acid 
1% for 1-2 hours and continued washing with PBS 
solution like before. Dehydration with multiple 
concentrated alcohol like 30%, 50%, 70%, 80%, 90% 
and absolute, 15-20 minute for every concentration. 
The following solution was Amyl acetate absolute as 
preservative solution until it becomes dry. Scaffold 
was dried with critical point drying (CPD) device. 
After sticking to pad stud (holder) with special glue 
and coating with pure gold with vacuum evapora-
tor, scaffold was ready to examine and photo with 
scanning electron microscope (JEOL JSM-T100 
Scanning Microscope, Japan).
Culture of hAMSC in Osteogenic Medium
Cultured hAMSCs were detached using 2 × tryp-
sin solution and seeded into 24-well microplate 
containing osteogenic medium, which composed 
of α-MEM medium supplemented containing 
50 μM ascorbate phosphate, 10 μM glycerol phos-
phate and 0.1 μM dexamethasone, for osteogenic 
study. The medium was changed every 3 days. 
The cells were cultured in the osteogenic medium 
for 21 days to induce osteoblastic differentiation. 
After complete differentiation had been estab-
lished morphologically, the cells were used for 
histochemical staining and immunohistochem-
istry studies. Cell fixation was performed by first 
detaching the cells from the petri dish of both 
media, followed by seeding into 24-well plate 
containing 10% formaldehyde. The presence of 
calcium deposits in the cultures was determined 
using Alizarin Red stain according to a standard 
protocol to evaluate osteogenesis.Figure 1 Chitosan scaffold
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RESULT
Human Amniotic Membrane Procurement
Amniotic membrane obtained using cesarean section 
under aseptic condition did not exhibit any growth 
of cell cultures which were not contaminated. After 
delivery through cesarian section and the umbili-
card cord cutted off, the placenta with the remain-
ing umbilicard cord was then evacuated and placed 
in a sterile kidney-shape stainless steel receptacle. 
Then amniotic membrane was peeled off from the 
underlying tissue which was the chorion and cut out 
from the placenta. Subsequently the membrane was 
washed by immersing it repeatedly in two bottles that 
contains PBS to remove blood and finally immersed 
in the third bottle containing medium DMEM/F12 
complemented with antibiotic and antifungal agents.
Isolation and Culture of hAMSC
Cells growth were observed for the first 24 hours, 
during that period the cells were mostly round or 
oval in shape (Figure 2a). After 24 hours observa-
tion, most of the cells were adherent to the plate 
and became spindle in shape. After the third day 
of observation the cells had grown to a confluence 
of 90% and congregated to form a swirling pattern 
(Figure 2b). Cell splitting procedure was performed 
fourteen times during this study before the cells 
were ready for subsequent examination.
Phenotypic Characterization of hAMSCs
IMMUNOCYTOCHEMISTRY
Immunocytochemistry testing revealed that the 
target cells expressed strong mesenchymal stem cell 
marker CD 105 (Figure 3). 
FLOWCYTOMETRY
In flow cytometry, we did characterization at 
passage 10. The result showed that CD44 was the 
most significant and abundant surface receptors. 
Other MSCs markers showed smaller number of 
Figure 2  Culture of hAMSCs. The first 24 hours the cells were mostly round or oval in shape [2] (a) after 
the third day most of the cells were adherent to the plate, exhibiting spindle-shape or fibro-
blast-like cell morphology with colonies swirling in pattern, and has reached confluence 
(b) (inverted microscope, 200× magnification)
Figure 3  Phenotypic characterization of hAMSC. The immunocytochemistry result showed that the 
cells strongly expressed CD105 (top left) and weakly expressed CD45 (top right)
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hAMSCs subpopulation, such as CD90 and CD 45 
(Figure 4).
Cell Proliferation Measurement on CA-ChSs
The result of toxicity tests with MTT Assay showed 
that the scaffold Chitosan-Carbonate Apatite 
(Ch-CA) was not toxic to hAMSC culture. In fact, 
the number of viable cells in chitosan-carbonate 
apatite was 66.59%. This suggests that combining 
chitosan and CA have a good biocompatibility 
against human amniotic mesenchymal stem cells, 
for cell proliferation more than 50% on a scaffold 
chitosan-carbonate apatite.
SEM Images of CA-ChSs
The result of examination and photo with SEM 
showed that cells could attached to the porosity 
surface of the scaffold CA-Ch (Figure 5).
Osteogenic Potential Differentiation Study 
of hAMSC
To test the osteogenic differentiation potential of 
hAMSC obtained from the process of isolation 
and culture, conducted in cell culture in a special 
medium that contains components that can induce 
osteoblastic differentiation. To determine the 
degree of osteogenesis hAMSC, the osteogenic 
culture was added with Alizarin Red solution that 
could detect the formation of calcium in the cell as 
an indicator of osteoblast cells (Figure 6).
DISCUSSION
Procurement of amniotic membrane procedure 
should be executed under highly aseptic condi-
tion because slight contamination of the sample, 
for example in normal delivery, may inevitably 
cause fungal growing on the cell culture. Isolation 
protocol was done in the Laboratory of Stem cell 
Research and Development Center, following 
Figure 4  The flow cytometry (a) showed that the majority hAMSCs sub-
population expressed CD44 and (b) with smaller subpopulation 
expressed CD90 and only an even small number expressed CD45
Figure 5  Cell could attach and proliferate among the pores of the scaf-
fold (SEM, 1000× magnification)
Figure 6  Staining with Alizarin Red the osteogenic medium exhibited large clusters with bright red appearance indicating the pres-
ence of extracellular mineral deposit. (A) while the normal medium showed no color changes detected (B) (Alizarin Red 
staining, counter-stained with Mayer’s hematoxylin, 200× magnification)
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Airlangga University protocol and adopted from 
modified Kamadjaja study.20 Isolated cells showed 
spindle-shaped fibroblast-like cells which adhered 
to the petri dish and when cell confluence was 
achieved the cell colonies formed a swirling 
pattern. This finding was consistent with the 
morphological characteristics of mesenchymal 
stem cell seen in many studies found in litera-
tures.14 Immunocytochemistry and flowcytometry 
on the target cells showed insubttantial expression 
of CD45, the specific phenotypic markers of hema-
topoeitic stem cell.
Results obtained during this research 
found distinct characterization of hAMSCs. 
Characterization was done using immunocyto-
chemistry and flowcytometry study on different 
passage. Immunocytochemistry testing showed 
that CD105 was strongly expressed with weak 
expression of CD45 on passage 8. On the contrary, 
flowcytometry study that was done on passage 10, 
majority of the hAMSCs subpopulation expressed 
CD44, smaller subpopulation expressed CD90 
and hematopoetic markers CD45. Other studies 
also mentioned that positive expression of CD73, 
CD90, and CD105 were found as a characteristics 
of mesenchymal marker, and other criteria for 
MSC characterization was only less than 2% of 
the MSC population will express CD34, CD45, 
CD11b, CD14, CD79, CD19, and HLA class II.21 
Similar to this study, Leyva-Leyva et al observed 
that 82% of the cells population shared CD73 and 
CD44 antigens, but only 0.08% expressed CD105 
on their surface. MSC marker expression can also 
be significantly influenced by cell passage, CD105 
expression reached its maximum (10%) after the 
first and second passages, but after the third and 
fourth passages, the expression fell down to 2%. 
This explain the weak CD105 expression and 
mostly negative cell subpopulation in 10th passage 
during flow cytometry examination.22
In the present study, we attempted to combine 
chitosan with CA in making CA-ChSs. The opti-
mal amount of chitosan powder was 200 mg and 
CA was 100 mg.11 Fabrication of CA-ChSs was 
based on lyophilization technique. Desalination 
of CA-ChSS was conducted to remove alkaline 
salt ions. The result was scaffold that had retentive 
form without brittleness, sponge-like, and not 
solid. Based on SEM images it was showed that 
CA-ChSs had three dimensional structure with 
many pores and hAMSc could attached and prolif-
eration among the porosity of the scaffold. The 
interconnected porous structure of the scaffolds 
had good retentive forms and ability to support 
the proliferation and differentiation of osteoblasts. 
Scaffolds used for tissue engineering ideally should 
have porous structure with pore size ranging from 
40-300 µm allowing tissue in growth and vascular 
tissue migration.1,4,11
The result of cell proliferation on CA-ChSs by 
MTT assay was 66.59%. It means that by combining 
Chitosan with CA had good biocompatibility to the 
human amnion mesenchymal stem cells, because 
cell proliferation more than 50% on CA-ChSs.
Alizarin Red staining was performed to detect 
osteoblastic differentiation in cell cultures by iden-
tifying the presence of extracellular calcium depos-
its. Stained osteoblasts would appear bright red in 
color whereas undifferentiated MSCs did not show 
color changes.23 This method is highly effective 
yet simple. In this study, the osteogenic-induced 
culture showed a significant amount of red-stained 
cell clusters, indicating that many of the hAMSCs 
collected were differentiated towards osteoblast 
lineage in osteogenic environment. The result of this 
study were consistent with other studies that showed 
which under certain induction conditions, stem 
cells isolated from the human amnion membrane 
could exhibit osteoblast differentiation.20,24
CONCLUSION
Based on the results of this study, it was concluded 
that hAMSc harvested from human amniotic 
membrane seeding in CA-ChSs had the capability 
for in vitro osteogenesis which made them to have 
the biggest potential for bone tissue engineering. 
However further studies should be done to explore 
its utilization potential in bone augmentation 
reconstruction. 
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